FDA Guidance for Industry: Q2(R2) Validation of Analytical Procedures

Title:
FDA Guidance for Industry: Q2(R2) Validation of Analytical Procedures
Origin/Publisher:

FDA

Content:
This guideline applies to new or revised analytical procedures used for release and stability testing of commercial drug substances and products (chemical and biological / biotechnological).

Go back